ROME Therapeutics Stock

rometx.comHealthcare / BioTech & PharmaFounded: 2020Funding to Date: $199MM

ROME Therapeutics develop novel therapies for cancer and autoimmune diseases by leveraging new insights from the vast uncharted territory of the repeatome, the human genome consisting of repetitive sequences of nucleic acids, known as repeats, long dismissed as "Junk DNA".

Register To Buy and Sell Shares

For more details on financing and valuation for ROME Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access ROME Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like ROME Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Frequently Asked Questions About ROME Therapeutics’ Stock

Can you buy ROME Therapeutics’ stock?
ROME Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy ROME Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell ROME Therapeutics’ stock?
Yes, you can sell stock of a private company like ROME Therapeutics. Forge can help you sell your ROME Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is ROME Therapeutics’ stock price?
ROME Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access ROME Therapeutics’ private market stock price with Forge Data.
What is ROME Therapeutics’ stock ticker symbol?
ROME Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Updated on: May 23, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.